EU approves Trimbow for asthma – Chiesi
The European Commission has approved a marketing authorisation for triple combination Trimbow (beclometasone + formoterol + glycopyrronium) from Chiesi, for patiemts with asthma therapy.
The European Commission has approved a marketing authorisation for triple combination Trimbow (beclometasone + formoterol + glycopyrronium) from Chiesi, for patiemts with asthma therapy.
An international team of researchers led by the Universities of Liverpool and Keele, working with Public Health England, has found that the common anticoagulant drug heparin inhibits the… read more.
A new modelling study has estimated that from 2000 to 2030 vaccination against 10 major pathogens
Novo Nordisk announced that the Committee for Medicinal Products for Human Use (CHMP), under the European Medicines Agency (EMA), adopted a positive opinion for the use of once-weekly… read more.
New research from the University of Sheffield has found being overweight is an additional burden on brain health and it may exacerbate Alzheimer’s disease.
Heart disease remains the leading cause of death worldwide, according to the American Heart Association’s Heart Disease and Stroke Statistics — 2021 Update,
Article written by Bruce Sylvester Women under 55 with type-2 diabetes have a 10-fold increased risk of developing coronary heart disease (CHD) during the two decades following diagnosis,… read more.
Interview and article by Christine Clark. Delayed diagnoses and more patients with advanced cancers were consequences of the coronavirus pandemic, according to Dr Erin Schenk, Assistant Professor, Thoracic… read more.
Interview and article by Christine Clark. Modern lung cancer treatment has changed the outlook for lung cancer patients considerably and interesting trial results are expected this year, according… read more.
Interview and article by Christine Clark. Dr Erin Schenk, Assistant Professor, Thoracic Oncology, University of Colorado describes the results of the ADAURA trial and the implications for her… read more.
Interview and article by Christine Clark IMI interviewed Dr Erin Schenk, Assistant Professor, Thoracic Oncology, University of Colorado to find out about key trial results in lung cancer… read more.
Article written by Christine Clark. During the past week Slovakia became the first European country to give formal approval for the use of ivermectin for both prophylaxis and… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.